| 000 | 01071 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515061823.0 | ||
| 264 | 0 | _c20070412 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(07)60438-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWalshe, J M | |
| 245 | 0 | 0 |
_aWilson's disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMar 2007 |
||
| 300 |
_a902 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aChelating Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHepatolenticular Degeneration _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPenicillamine _xadministration & dosage |
| 650 | 0 | 4 |
_aTrientine _xadministration & dosage |
| 650 | 0 | 4 |
_aZinc _xadministration & dosage |
| 773 | 0 |
_tLancet (London, England) _gvol. 369 _gno. 9565 _gp. 902 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(07)60438-3 _zAvailable from publisher's website |
| 999 |
_c16923321 _d16923321 |
||